Pansib, Bb Boy S.
HRN: 21-26-92 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/25/2022
AMPICILLIN 250MG (VIAL)
06/25/2022
07/01/2022
IV
105mg
Q12Hrs
Tc Neonatal Pneumonia
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes